Is automated sample preparation worth the investment for small labs?

For most small labs, automated sample preparation is worth the investment when throughput demands, regulatory requirements, or analyst workload have outgrown what manual methods can reliably deliver. The break-even point arrives faster than many lab managers expect, particularly when you factor in reduced solvent costs, fewer reruns, and the time analysts reclaim from repetitive manual steps. The questions below unpack the real costs, the realistic time savings, and the conditions that make automation a smart decision for a smaller operation.

What does automated sample preparation actually cost a small lab?

The upfront cost of an automated sample preparation system for a small lab typically ranges from tens of thousands to over a hundred thousand euros or dollars, depending on the platform, configuration, and the complexity of the analyses it needs to support. However, the purchase price is only one part of the total cost picture, and it is rarely the most useful number to focus on.

A more complete view of lab automation cost includes consumables such as SPE cartridges and disks, solvents, service contracts, and the time investment required for initial method setup and staff training. On the other side of the ledger, automation typically reduces organic solvent consumption substantially. Systems designed for persistent organic pollutant analysis, for example, can operate with less than 100 ml of solvent per sample and eliminate the need for dichloromethane entirely, which has meaningful implications for both reagent spend and waste disposal costs.

For small labs evaluating small laboratory equipment investments, leasing arrangements and phased purchasing are worth exploring. Some manufacturers and distributors also offer modular configurations, allowing a lab to start with a core system and expand capacity as workload grows, which spreads capital outlay over time and reduces the financial risk of committing to a full platform immediately.

How much time does automation save compared to manual preparation?

Automated sample preparation consistently delivers significant time savings over manual methods, with the most measurable gains coming from the elimination of hands-on analyst time during extraction, cleanup, and concentration steps. A process that requires several hours of active analyst attention manually can often run unattended overnight or across a full working day with an automated system.

Consider a practical example: a system like the SER-158 solvent extractor can process up to six solid or semi-solid samples in approximately 23 hours using less than 100 ml of solvent per sample, while simultaneously concentrating the extracts during the run. That same workload handled manually would require continuous analyst presence, careful solvent management, and separate concentration steps, consuming far more productive time per sample.

For SPE-based workflows, high-capacity platforms can process up to 80 samples in a single automated run across consecutive sequences. The practical implication for a small lab is that analysts can focus on instrument operation, data review, and client reporting during the time the system is running, rather than being tied to the bench. This shift in how analyst time is allocated is often the most compelling time-saving argument for automation, particularly in labs where headcount is limited.

What types of analyses benefit most from automated sample prep?

Analyses involving persistent organic pollutants, PFAS, pesticides, and other trace-level environmental contaminants benefit most from automated sample preparation. These applications share a common challenge: they require multi-step cleanup procedures to remove matrix interferences before detection, and those steps are both time-consuming and error-prone when performed manually.

Specifically, the following analytical areas see the greatest gains from automation:

Dioxins, PCBs, and PBDEs: Multi-layer cleanup is mandatory for regulatory compliance, and automated purification systems eliminate the variability introduced by manual column preparation and elution.
PFAS analysis: PFAS contamination from laboratory materials is a genuine concern in manual workflows. Automated systems with inert, Teflon-free flow paths significantly reduce the risk of background contamination that can compromise results.
Pesticide residues: High sample volumes and the need for consistent extraction efficiency across large batches make automated SPE a natural fit for pesticide screening workflows.
PAHs, hormones, and SVOCs in water: Large-volume water extraction is particularly well-suited to automation, where systems supporting multiple channels in parallel or series mode can handle the throughput demands that manual processing cannot match.
Food and feed matrices: High-fat samples require rigorous lipid removal before mass spectrometry measurement, a step that benefits greatly from reproducible automated cleanup.

In short, any analysis where sample matrix complexity, contamination risk, or regulatory traceability requirements place high demands on the preparation process is a strong candidate for automation.

Can a small lab realistically justify the ROI of laboratory automation?

Yes, a small lab can justify the laboratory automation ROI, but the justification needs to be built on honest numbers rather than optimistic assumptions. The strongest ROI cases rest on three pillars: analyst time recovered, error and rerun costs avoided, and the business capacity that automation unlocks.

On the cost side, consider what a failed batch costs a small lab. A manual preparation error that requires a full rerun does not just waste reagents and consumables; it delays client reporting, risks regulatory deadlines, and consumes analyst time that cannot be recovered. Automated systems with no direct sample-to-system contact eliminate a significant category of cross-contamination risk, which directly reduces the frequency of these costly reruns.

On the revenue side, automation expands what a small lab can offer. A lab that previously could process a limited number of samples per week due to analyst bandwidth can accept more work, take on new analytes, or offer faster turnaround times without proportionally increasing headcount. For labs that compete on accredited, high-quality results for dioxins, PCBs, or PFAS, the ability to reliably deliver compliant results at higher throughput is a genuine commercial differentiator.

The ROI calculation also needs to account for solvent savings. Reducing organic solvent consumption to under 100 ml per sample, and eliminating high-cost solvents like dichloromethane entirely, generates ongoing savings that compound over time and contribute meaningfully to the payback period.

What are the biggest risks of not automating sample preparation?

The biggest risks of staying with manual sample preparation in a small lab are throughput constraints, result variability, and competitive disadvantage as regulatory and client expectations continue to rise. These risks tend to compound quietly until they become acute problems.

Manual sample preparation introduces operator-dependent variability at every step: column packing, elution timing, solvent volumes, and concentration endpoints all vary between analysts and between days. For regulated analyses such as dioxins or PFAS in food and environmental matrices, this variability can translate into results that fail method validation criteria or that cannot be defended under audit. As accreditation bodies and clients increasingly scrutinize method performance data, labs relying on manual procedures face growing pressure to demonstrate reproducibility they may struggle to document.

There is also a safety dimension. Manual handling of chlorinated solvents and other hazardous reagents over extended periods carries occupational health implications that automated, closed systems largely eliminate. For a small lab with limited fume hood capacity or a small team, this is not a minor consideration.

Finally, there is the market risk. As more labs adopt automated platforms, turnaround times and pricing in the market shift. A small lab that cannot match the throughput or the cost structure of automated competitors may find it increasingly difficult to retain clients who have options.

When is the right time for a small lab to invest in automation?

The right time to invest in automated sample preparation is when the cost of not automating, measured in analyst time, reruns, missed capacity, and competitive pressure, begins to exceed the annualized cost of the system. In practice, several concrete signals indicate that a small lab has reached this point.

Analysts are spending more than a significant portion of their working week on repetitive manual extraction and cleanup steps, leaving insufficient time for instrument operation and data review.
The lab is turning away work or extending turnaround times because sample preparation is the bottleneck, not instrument capacity.
Rerun rates due to preparation errors or contamination are measurable and recurring.
Regulatory requirements for the lab’s key analytes are tightening, and manual method performance is approaching its limits.
The lab is planning to add new analytes, particularly PFAS, dioxins, or PCBs, that carry high preparation complexity from the outset.

Timing the investment to coincide with a method expansion or a new client contract can also help the financial case, as the new revenue stream contributes to the payback calculation from day one. Labs that wait until they are already overwhelmed typically find that the transition is more disruptive than it would have been if planned proactively.

Exploring sample preparation systems early, even before the decision is final, is worthwhile. Understanding what configurations are available, what applications they support, and how they integrate with existing workflows allows a lab to make a well-informed investment rather than a reactive one.

How DSP-Systems helps small labs transition to automation

DSP-Systems provides small and mid-sized laboratories with a practical path to automated sample preparation, combining the right equipment with the expertise to make it work from day one. Their offering is built around the specific analytical challenges that matter most to regulated labs.

GO-EHT purification systems for dioxins, PCBs, PBDEs, and PCNs, using less than 100 ml of solvent per sample with no cross-contamination risk
SPE2000 and AutoEmpore platforms for high-throughput PFAS, pesticide, and emerging contaminant extraction across a wide range of sample matrices
SER-158 solvent extraction for solid and semi-solid samples, fully compatible with downstream automated cleanup
Pre-installation programming, application testing, and configuration aligned with EPA and CEN standards
Method development support, training, and ongoing technical assistance for labs building new capabilities

Whether you are evaluating your first automated platform or expanding an existing workflow, the team at DSP-Systems can help you match the right system to your throughput needs and analytical scope. Get in touch with DSP-Systems to discuss your requirements and find out which solution fits your lab.